Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea - Test2 - elhamkhani - TriplyDB

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

http://www.wikidata.org/entity/Q28550455

about

Ebola virus disease and critical illness.Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.Neurological Complications of Ebola Virus Infection Clinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014-February 2015 Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea Vaccine testing for emerging infections: the case for individual randomisation Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections Insights from clinical research completed during the west Africa Ebola virus disease epidemic.Monoclonal antibodies for the treatment of Ebola virus disease.Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.Experimental Therapies for Ebola Virus Disease: What Have We Learned?Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.Crimean-Congo hemorrhagic fever in pregnancy: A systematic review and case series from Russia, Kazakhstan and Turkey Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa.Operational Research during the Ebola Emergency.A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea.In silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitors Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.A Systematic Review of Ebola Treatment Trials to Assess the Extent to Which They Adhere to Ethical Guidelines.Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted.Ebola virus RNA detection on fomites in close proximity to confirmed Ebola patients; N'Zerekore, Guinea, 2015.Ebola Virus Disease in Children, Sierra Leone, 2014-2015.Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015.Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses.Characteristics and Outcomes of Pediatric Patients With Ebola Virus Disease Admitted to Treatment Units in Liberia and Sierra Leone: A Retrospective Cohort Study.Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus.Responding to ever-changing epidemiological dynamics of Ebola virus disease.Clinical Evaluation of Ebola Virus Disease Therapeutics.Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.First Newborn Baby to Receive Experimental Therapies Survives Ebola Virus Disease.Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles.Clinical Management of Ebola Virus Disease Patients in Low-Resource Settings.Discovering Drugs for the Treatment of Ebola Virus.Novel Stable Ebola Virus Minigenome Replicon Reveals Remarkable Stability of the Viral Genome.Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease: a case report.Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review.

P2860

Q26250274-EFAD7D9D-964B-45D1-89FF-3CD8C97634BB Q28076034-C3B4BC27-0951-42BF-B622-C4D433F22C46 Q28385386-D9F45A77-BD76-449F-B816-AAAA80177426 Q28387286-4D9EE337-AEE5-4752-9D7B-EA1AF6FA47A3 Q29247868-223B8636-51D8-4B2A-B8D8-0CF981C11480 Q29451722-283D24AC-BCC0-4BC6-A580-5C3B9728B735 Q29994672-9AA2DF20-C838-4E97-9E44-4A2C2A813D45 Q30234590-8BE70C87-7F4D-4F6C-966D-3539C818067B Q30245073-E057D823-A8B6-4717-B115-228ADC97AF2D Q30251949-D35D2F9A-093E-4352-987E-8254F3F035F6 Q30275032-91B3F003-E704-42E7-B6B9-0B7575342529 Q33439713-21E87355-80A8-4891-80E4-AB9EB0B8726F Q33646611-16E3707A-98DE-4DDF-B5F0-14566847BEBB Q33825147-67D5CD9D-2C2B-452D-B21B-6F1B271AF3B4 Q33908088-95EEBD13-FF2A-4DED-93AE-8E482130D9DD Q34542427-6B4FB983-4933-47DB-A2EB-325329A91F19 Q35969404-475B1044-51BF-49DE-8F31-B803EA0CFEC3 Q36136841-0073CA69-C63B-4FE5-BF11-DF7F88474D32 Q36166222-4F1E8DDD-87E0-4085-A80E-3C53BCBA7AD9 Q36251369-DB14E872-551B-4EF9-B827-92EA6EBA3C47 Q36287337-EFA8DF6C-E8D2-423E-9608-5F569F17C197 Q36288297-78D2B358-48B0-4B19-B193-6E9B406E966B Q36369069-AEA295C5-CF12-44A8-8612-60DFD8E8CB03 Q37288197-A6755DDA-3B92-4354-B398-389FD44CB5CA Q37310771-FE9036FB-65FB-44A9-B9EB-636D6B97ADC3 Q37535900-F9A07A92-DD35-4270-8649-A6138946D1D3 Q37538706-82CA8175-4344-4310-9E80-F4A171A6E569 Q37591266-EDADBA18-1171-4E8C-B596-CD717065518F Q37593571-3F87FD92-3627-4F3D-9B39-ADC99E6BC600 Q37659878-FF4A0C31-5C60-4E26-A6F0-E645FB32D0B4 Q38617605-15AA8E49-BEB0-4170-B439-829D9DEF702D Q38638782-CDE93046-A4FB-44B1-AAC8-6197647169EA Q38981209-FC0ED1FB-7280-4A95-8CC2-104E3073479D Q39175134-7E0EDE7D-6CA0-4B92-BF0D-5F3D9EF4554E Q39483664-146B5E19-4E52-47B8-950F-10F19FD08435 Q40039706-AFBC14FF-F535-455B-98CD-A6738CCD77BC Q40040437-7EFA99F0-835B-4374-BF2A-025AA6F96BB4 Q40041370-EB81A0C8-D481-4E8E-ADBD-3AEBB9C12AA7 Q40044875-C5F31103-4AE6-41C8-AC4B-D9DFD47F7859 Q40045378-FC8ECA0F-B4F0-4B05-9CAA-E715467740F1

P2860

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

http://www.wikidata.org/entity/Q28550455

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@ast

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@en

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@nl

type

label

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@ast

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@en

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@nl

prefLabel

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@ast

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@en

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@nl

P1433

Q28550455-FEF678D8-D3BD-49A0-B31F-8104B24C3872

P1476

Q28550455-1150B05F-F5A7-414A-9B6B-1A538956801D

P2093

Q28550455-049489D4-6513-4D10-BDB6-151A9FC965E0

Q28550455-05193E6F-78FE-4BFA-AAFD-5161935DC05D

Q28550455-09880D15-BF04-44D9-92DE-998559CCD064

Q28550455-0CFB1D60-B125-4183-8FC8-E87B1771346E

Q28550455-0D046B65-DC6E-472B-A089-CC8A591777F0

Q28550455-0F67E765-16C8-42C9-B694-ED60A71036A9

Q28550455-0F833752-1076-4D8B-80A9-02B8B2251362

Q28550455-108E45A2-E91A-4584-84A4-DC0FAB9461C5

Q28550455-13BA711B-F323-45AA-8254-F620AD939106

Q28550455-149428EF-D4E3-442E-85FE-4EB5A08F5A67

P2860

Q28550455-02A105B5-B0D8-4766-8A42-93C0F70DF0C0

Q28550455-0596F1BD-E75E-4EC8-A135-3EE13C72A092

Q28550455-1188E3F6-65B3-4277-89BA-19D1032D3EA3

Q28550455-1352A9C5-BFA9-4148-BD9E-C8E2748C8516

Q28550455-136062D0-36F1-4770-99E4-0ED42B185137

Q28550455-1A940F43-BB85-4989-98E6-76A18EA6597A

Q28550455-1AF3D2A1-B18E-40B0-BEAE-71FEF258667F

Q28550455-219190AF-343C-4C04-BB00-1314F3D57226

Q28550455-22145BE7-78F6-42F9-B060-3CE5AF1B8811

Q28550455-23340808-B7B9-40AC-8221-6CDCEF5A7C38

P304

Q28550455-BC0A60AC-E0B0-4B82-A045-93ECF5D8F194

P31

Q28550455-52E71953-0D42-4865-BB7B-6A881DB54C84

P3181

Q28550455-AD35202E-F93F-4052-B5B1-4915D2363C3D

P356

Q28550455-A1180773-939E-4804-96BF-ADD756C3627D

P407

Q28550455-34168472-B1B5-41E9-B5E3-AC3193E5D7CC

P433

Q28550455-2AED8E7E-E056-41F2-A04C-2769603D9074

P478

Q28550455-455D2655-300B-42B8-A9A1-A8A80522EB98

P50

Q28550455-0131B30A-E546-4314-9A67-F7925E71BF7C

Q28550455-1016BCF1-B0FC-4C03-9F01-A83790842616

Q28550455-1638BF96-CDCB-4512-8AB9-E5E28D2035E7

Q28550455-3BB089A1-8E2A-4CC1-9402-D42D9CB6A4D3

Q28550455-4DE669F9-DA2D-4A77-8C14-82A3827139D2

Q28550455-5285F14B-0944-4F95-B736-A5598DA20F89

Q28550455-5C45BDB8-331B-476B-B09D-30828AAA375C

Q28550455-739F5286-02DE-4B7F-9201-ADD2E1245694

Q28550455-7F89A719-7DD4-4FC7-9FB6-58C9E7BEC409

Q28550455-85B74382-5A5C-4CEA-BB83-5104D6CC1582

P577

Q28550455-A0E30EDD-B59E-443C-809F-0647B84EA750

P5875

Q28550455-319280A6-79F3-446A-8EC0-34120BB81449

P698

Q28550455-C16CCB99-2CF3-443A-8179-FE5BEF3FB490

P921

Q28550455-2D263BB2-F8AB-4F7E-989F-707765B4B63B

Q28550455-4CD3A44F-ACA5-4FCA-852E-B0FD37E1392D

Q28550455-D7E5E862-5E8B-459D-B270-012775C7D98E

Q28550455-a80fb693-4263-133f-d448-a8b5aea2288a

Q28550455-d74eae1c-47f3-3401-5f7a-135b279ef1c3

P932

Q28550455-778C8BF2-CA1C-4FB2-BAB7-93E6589848B9

P3181

P356

JOURNAL.PMED.1001967

P1433

P1476

Experimental Treatment with Fa ...... oof-of-Concept Trial in Guinea

@en

P2093

Abdoul-Bing M'Lebing

http://www.w3.org/2001/XMLSchema#string

Abdoul-Habib Beavogui

http://www.w3.org/2001/XMLSchema#string

Abdoulaye Soumah

http://www.w3.org/2001/XMLSchema#string

Aboubacar Youla Sidiboun

http://www.w3.org/2001/XMLSchema#string

Adele Milinouno

http://www.w3.org/2001/XMLSchema#string

Alexandra Fizet

http://www.w3.org/2001/XMLSchema#string

Alexis Tounkara

http://www.w3.org/2001/XMLSchema#string

André Bongono

http://www.w3.org/2001/XMLSchema#string

André Maomou

http://www.w3.org/2001/XMLSchema#string

Annabelle Lefevre

http://www.w3.org/2001/XMLSchema#string

P2860

Filoviral immune evasion mechanisms

Multivariate or multivariable regression?

Ebola haemorrhagic fever

Ebola transmission linked to a single traditional funeral ceremony - Kissidougou, Guinea, December, 2014 - January 2015

Emergence of Zaire Ebola Virus Disease in Guinea

Ebola Virus Disease: Focus on Children

Severe sepsis and septic shock

Structural basis for Marburg virus VP35-mediated immune evasion mechanisms

Two-sided confidence intervals for the single proportion: comparison of seven methods

Evaluating clinical trial designs for investigational treatments of Ebola virus disease

P304

e1001967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

879542

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.1001967

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Stephan Günther

Xavier de Lamballerie

Antonino Di Caro

Sophie Duraffour

Jean-Marc Tréluyer

Khaled Ezzedine

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296624391

http://www.w3.org/2001/XMLSchema#string

P698

26930627

http://www.w3.org/2001/XMLSchema#string

P921

2014 Ebola virus epidemic in Guinea

Ebola virus disease

P932

4773183

http://www.w3.org/2001/XMLSchema#string